BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28105347)

  • 1. Pulmonary intravascular large B-cell lymphoma successfully treated with rituximab, cyclophosphamide, vincristine, doxorubicin and prednisolone immunochemotherapy: Report of a patient surviving for over 1 year.
    Nishii-Ito S; Izumi H; Touge H; Takeda K; Hosoda Y; Yamasaki A; Kuwamoto S; Shimizu E; Motokura T
    Mol Clin Oncol; 2016 Dec; 5(6):689-692. PubMed ID: 28105347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of lung intravascular large B cell lymphoma developed with respiratory failure rescued by corticosteroid prior to definite diagnosis.
    Tsuji M; Kondo M; Onizawa F; Shishime O; Muramatsu S; Matsuo Y; Sakai S; Tanaka J; Tagaya E
    Respir Med Case Rep; 2022; 37():101625. PubMed ID: 35309974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary intravascular large B-cell lymphoma accompanying synchronous primary pulmonary adenocarcinoma and benign interstitial lesions.
    Satoh T; Arai E; Kayano H; Sakaguchi H; Takahashi N; Tsukasaki K; Yasuda M
    J Clin Exp Hematop; 2019 Sep; 59(3):140-144. PubMed ID: 31391407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung intravascular large B-cell lymphoma with ground glass opacities on chest computed tomography: a case report.
    Xiao D; Fu C; Long X; Liu W; Chen C; Zhou J; Fan S
    Int J Clin Exp Pathol; 2014; 7(8):5285-90. PubMed ID: 25197411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
    Shimada K; Yamaguchi M; Atsuta Y; Matsue K; Sato K; Kusumoto S; Nagai H; Takizawa J; Fukuhara N; Nagafuji K; Miyazaki K; Ohtsuka E; Okamoto M; Sugita Y; Uchida T; Kayukawa S; Wake A; Ennishi D; Kondo Y; Izumi T; Kin Y; Tsukasaki K; Hashimoto D; Yuge M; Yanagisawa A; Kuwatsuka Y; Shimada S; Masaki Y; Niitsu N; Kiyoi H; Suzuki R; Tokunaga T; Nakamura S; Kinoshita T
    Lancet Oncol; 2020 Apr; 21(4):593-602. PubMed ID: 32171071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case report of primary prostate intravascular large B cell lymphoma presenting as prostatic hyperplasia.
    Zhu F; Pan H; Xiao Y; Li Q; Liu T; Liu X; Wu G; Li J; Zhang L
    Medicine (Baltimore); 2019 Dec; 98(50):e18384. PubMed ID: 31852153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of pulmonary intravascular lymphoma treated with CHOP chemotherapy plus rituximab].
    Ohkubo H; Yoshida T; Ohta K; Takaku T; Katagiri T; Paku J; Kasuga I; Minemura K; Gotoh A; Serizawa H; Mukai K; Ohyashiki K
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):553-6. PubMed ID: 15853227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timely Diagnosis and Successful Treatment of Intravascular Large B-Cell Lymphoma in an Elderly Patient with Poor Performance Status.
    Kaito S; Muto H; Miyawaki S; Ohashi K; Tomiyama J
    Am J Case Rep; 2019 Jun; 20():780-784. PubMed ID: 31155607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
    Fridrik MA; Jaeger U; Petzer A; Willenbacher W; Keil F; Lang A; Andel J; Burgstaller S; Krieger O; Oberaigner W; Sihorsch K; Greil R
    Eur J Cancer; 2016 May; 58():112-21. PubMed ID: 26990931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
    Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
    Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fever and nonspecific pulmonary lesions--a rare differential diagnosis].
    Bollinger CR; Theegarten D; Dührsen U; Metz KA
    Dtsch Med Wochenschr; 2007 Nov; 132(48):2563-6. PubMed ID: 18033651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diffuse large B-cell lymphoma relapsing with intravascular large B-cell lymphoma-like perivascular and intravascular lesions].
    Ishikawa T; Fukumi T; Moriyama T; Murakami H; Nagakita K; Yoshioka T; Makita M; Shinno Y; Sunami K
    Rinsho Ketsueki; 2019; 60(10):1455-1461. PubMed ID: 31695007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular large B-cell lymphoma appearance on dual-energy computed tomography: a case report.
    Yamada D; Imai R; Matsusako M; Kurihara Y
    BMC Pulm Med; 2023 Apr; 23(1):125. PubMed ID: 37072746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravascular large B-cell lymphoma with massive pulmonary lesions].
    Higashiyama A; Hashino S; Onozawa M; Takahata M; Okada K; Kahata K; Taniguchi N; Nasuhara Y; Kubota K; Fujimoto N; Matsuno Y; Nishimura M; Asaka M
    Rinsho Ketsueki; 2010 May; 51(5):353-6. PubMed ID: 20534958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravascular large B-cell lymphoma as a cause of hypopituitarism: gradual and late reversal of hypopituitarism after long-term remission of lymphoma with immunochemotherapy.
    Pekic S; Milicevic S; Colovic N; Colovic M; Popovic V
    Endocrine; 2008; 34(1-3):11-6. PubMed ID: 18937075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse large B-cell lymphoma in a patient with dermatomyositis-associated interstitial lung disease: A case report.
    Li S; Sun Y; Shao C; Xu K; Huang H
    Thorac Cancer; 2019 Oct; 10(10):2035-2039. PubMed ID: 31452347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary intravascular large B-cell lymphomamanifesting as interstitial pneumonias: report of 2 cases and review of literature].
    Zhao TT; Cao MS; Zhang YW; Dai JH; Meng FQ; Cai HR
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Feb; 40(2):108-113. PubMed ID: 28209041
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary Intravascular B-Cell Lymphoma with Angiotropism/Angioinvasion Mimicking Interstitial Lung Disease: A Clinical Dilemma and Potential Diagnostic Challenge.
    Matea F; Alowami S; Bonert M; Sur M; Shargall Y; Naqvi AH
    Case Rep Hematol; 2018; 2018():3821392. PubMed ID: 30402301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained remission after rituximab-containing chemotherapy for intravascular large B-cell lymphoma.
    Shimada K; Kosugi H; Narimatsu H; Shimada S; Suzuki T; Ito M; Kinoshita T; Mori N; Naoe T
    J Clin Exp Hematop; 2008 Apr; 48(1):25-8. PubMed ID: 18434690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological analysis on adhesive molecules of renal intravascular large B cell lymphoma treated with CHOP chemotherapy and rituximab.
    Kusaba T; Hatta T; Tanda S; Kameyama H; Tamagaki K; Okigaki M; Inaba T; Shimazaki C; Sasaki S
    Clin Nephrol; 2006 Mar; 65(3):222-6. PubMed ID: 16550755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.